No Data
Hong Kong stock abnormal fluctuation | More Medical Technology (02576) fell by over 11% again, with the stock price nearly halved after 5 days of listing. The company has accumulated losses of over 1.2 billion yuan in three years.
Taimai Medical Technology (02576) fell by over 11% again. Since its listing on October 8th, the stock has been declining for 5 trading days in a row, and the current stock price is close to halving compared to the HK$13 IPO price.
"The first stock of medical SaaS" Taimei Medical Technology (2576.HK) went public, adding a new star to the life science digitalization track.
Recently, many companies have submitted batches of documents, and IPO projects have also shown a significant acceleration, including high-quality investment targets that the market is looking forward to. On October 8th, 'the first stock of medical SaaS (software as a service)' TaiMei Medical Technology officially went public. As the first Hong Kong stock listed after the National Day holiday, and with endorsements from star-studded institutions such as Hillhouse Capital and Tencent, TaiMei Medical Technology has attracted the attention of many investors. 1. Drawing lessons from others: TaiMei Medical Technology, formerly underestimated by the US stock market, focuses on digital solutions in the life science sector of medicine and medical instruments industry, by designing and providing industry-specific.
The stock price has fallen by nearly 40% in the first two days of listing. TaiMei Medical Technology (02576) continues to struggle with losses, finding it difficult to sell its products.
Both recently listed on IPO, Taimei Medical Technology (02576) has become the "background board" of the hot IPO market in Hong Kong.
Express News | TaiMei Medical went public and immediately fell by 30%: The common problem of SaaS remains unsolved, revenue growth rate has dropped to single digits, continuous losses and customer churn.
Zhejiang Taimei Medical Technology Opens 14% Lower in Hong Kong Trading Debut
Too Medical Technology (2576.HK) today landed on the Hong Kong Stock Exchange as China's largest provider of digital solutions for pharmaceutical and medical equipment research and development.
October 8th, Great Wall News: Too Beauty Medical Technology (2576.HK) listed on the Hong Kong Stock Exchange today, with an issue price of 13.00 Hong Kong dollars per share, joint sponsors are Morgan Stanley and China International Capital Corporation. Too Beauty Medical Technology is a digital solution provider focusing on the pharmaceutical and medical instrument industry in China, designing and offering industry-specific software and digital services to facilitate research and development, as well as marketing of pharmaceuticals and medical instruments. The company's global offering this time includes 25.779 million H shares, with approximately 50% being publicly offered in Hong Kong. Each board lot consists of 200 shares, and the Hong Kong public offering received 156.3 times oversubscription. The prospectus shows that Too Beauty...
No Data
No Data